{"product_id":"michigan-medicine-19th-annual","title":"Michigan Medicine 19th Annual Advanced Liver Disease and Liver Transplantation Update 2025","description":"\u003ch1 class=\"product_title entry-title\"\u003eMichigan Medicine 19th Annual Advanced Liver Disease and Liver Transplantation Update 2025\u003c\/h1\u003e\n\u003cstrong\u003e+ Include: 12 videos + 1 pdf, size: 3.62 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: hepatologists, gastroenterologists, transplant surgeons, internists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003e\n\u003cbr\u003e\u003cbr\u003eDate \u0026amp; Location:  Friday, April 11, 2025, 7:30 AM – 3:00 PM EST, Sheraton Detroit Novi Hotel, Novi, MI\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eTarget Audience\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Family Medicine, Gastroenterology, General Medicine, Hepatology, Internal Medicine, Primary Care, Surgery, Transplant Surgery\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eProfessions\u003c\/em\u003e – House Officer, Nurse, Nurse Practitioner, Other Healthcare Professional, Physician, Physician Assistant, Social Worker\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eOverview\u003c\/div\u003e\u003cbr\u003eJoin this hybrid program in person or virtually. This course will provide an update on recent developments in the management of patients with advanced liver disease including recent improvements in the medical management of steatotic liver disease, alcohol use disorder and alcoholic liver disease, and hepatic complications of heart disease. In addition, updates on acute on chronic liver failure, evaluation of substance use disorders in patients with advanced liver disease, liver transplantation for patients with metastatic colorectal cancer and neuroendocrine tumors, use of marginal organs in liver transplantation, and the medical management of long-term liver transplant recipients will be provided.\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003eObjectives\u003c\/div\u003e\n\u003cdiv\u003eAt the conclusion of this activity, learners will be able to:\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eimplement newer approaches to the diagnosis, staging, and treatment of patients with metabolic associated liver disease\u003c\/li\u003e\n\u003cli\u003euse appropriate diagnostic tools and treatment strategies for patients with alcoholic liver disease\u003c\/li\u003e\n\u003cli\u003eunderstand and recognize common hepatic manifestations of patients with congenital and acquired heart disease\u003c\/li\u003e\n\u003cli\u003eunderstand current classification schemes and medical recommendations for patients with acute on chronic liver failure\u003c\/li\u003e\n\u003cli\u003eimplement how to evaluate and treat patients with substance use disorders with underlying liver disease\u003c\/li\u003e\n\u003cli\u003eunderstand new data on the indications and outcomes with liver transplantation for patients with metastatic colorectal cancer and neuroendocrine tumors to the liver\u003c\/li\u003e\n\u003cli\u003eunderstand what is considered a “marginal organ” for liver transplantation and how they fare in adult recipients\u003c\/li\u003e\n\u003cli\u003eimplement medications and treatments that are recommended for LT recipients with hyperlipidemia, cancer and metabolic bone disease\u003c\/li\u003e\n\u003c\/ol\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAgenda.pdf\u003c\/li\u003e\n\u003cli\u003eAcute on Chronic Liver Failure.mp4\u003c\/li\u003e\n\u003cli\u003eDetection and Management of ALD in the Outpatient Setting.mp4\u003c\/li\u003e\n\u003cli\u003eInteractive Case 1 A Transplant Candidate with AUD.mp4\u003c\/li\u003e\n\u003cli\u003eManagement of Hyperlipidemia, Cancer, and Osteoporosis Post Liver Transplant.mp4\u003c\/li\u003e\n\u003cli\u003eMedical Treatments for Steatotic Liver Disease.mp4\u003c\/li\u003e\n\u003cli\u003ePanel Questions \u0026amp; Answers 1.mp4\u003c\/li\u003e\n\u003cli\u003ePanel Questions \u0026amp; Answers 2.mp4\u003c\/li\u003e\n\u003cli\u003ePanel Questions \u0026amp; Answers 3.mp4\u003c\/li\u003e\n\u003cli\u003eSubstance Use Disorders in Advanced Liver Disease Patients.mp4\u003c\/li\u003e\n\u003cli\u003eThe Heart – Liver Connection.mp4\u003c\/li\u003e\n\u003cli\u003eTransplantation for Metastatic Colorectal Cancer and Neuroendocrine Tumors.mp4\u003c\/li\u003e\n\u003cli\u003eUse of Marginal Organs in Liver Transplantation.mp4\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954500079714,"sku":"MED-AMB04714","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Michigan-Medicine-19th-Annual-Advanced-Liver-Disease-and-Liver-Transplantation-Update-2025.jpg?v=1779378175","url":"https:\/\/meducourse.com\/products\/michigan-medicine-19th-annual","provider":"Meducourse","version":"1.0","type":"link"}